Sarah Binhassan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sarah Binhassan has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Manal Abudawood
Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia
2 shared publications - Abdul Ali Peer Zada
Department of Medical Genetics and Molecular Pathology, Pathology and Clinical Laboratory Medicine Administration King Fahad Medical City Riyadh Saudi Arabia
1 shared publication - Abdulfatah Alazmah
Department of Pediatric Dentistry, College of Dentistry, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia
1 shared publication - Abdullah Khalid Bakarman
King Saud University, Riyadh, Saudi Arabia
1 shared publication Abdullah M. Alsoghier
Department of Oral Medicine and Diagnostic Sciences, College of Dentistry, King Saud University, Riyadh, Saudi Arabia
1 shared publication- Azizah AlSwayed
Molecular Pathology, Research Center and Hematology Section, Pathology and Clinical Laboratory Medicine Administration, King Fahad Medical City, Riyadh, Saudi Arabia
1 shared publication
Latest Publications
- Open Access
- 24 March 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (7) , 961
Comparative Detection and Inter-Modality Agreement of Pulp Stones Using Digital Periapical Radiography and CBCT at Two Voxel Sizes: An Ex Vivo Study
Background/Objectives : Pulp stones are calcified masses within the dental pulp that may complicate endodontic procedures. Although cone beam computed tomography (CBCT) has been reported to detect pulp stones more frequently than two-dimensional radiography, direct comparisons between digital periapical radiography (DPR) and CBCT, particularly at different voxel sizes, remain limited. This study aimed to compare pulp stone detection rates between DPR and CBCT acquired at two voxel sizes and to evaluate inter-modality agreement using a location-based analysis for pulp stone identification in extracted teeth. Methods: Fifty-two extracted human teeth were examined using DPR and CBCT at voxel sizes of 0.2 mm and 0.1 mm under standardized ex vivo conditions. Pulp stones were evaluated in the coronal and radicular regions using a binary scoring system (presence/absence). Detection rates were compared across imaging modalities, and inter-modality agreement was evaluated using McNemar’s test in the analysis stratified by pulp stone location. Associations between pulp stone detection and age, gender, tooth status, and stone location were explored using chi-square tests. Results: CBCT at 0.1 mm demonstrated the highest detection rate for pulp stones (63.5%), followed by CBCT at 0.2 mm (57.7%) and DPR (50%), with no statistically significant differences among modalities (p > 0.05). Agreement analysis showed that CBCT at 0.2 mm had higher agreement with CBCT at 0.1 mm than DPR, particularly in the coronal region, whereas DPR showed lower agreement in the radicular region. No significant associations were observed between pulp stone detection and age, gender, or tooth status. Conclusions: Under standardized ex vivo conditions, CBCT showed numerically higher pulp stone detection rates than DPR. Location-based agreement analysis indicated greater consistency between CBCT voxel sizes than between CBCT and DPR, particularly in the radicular region. These findings highlight differences in pulp stone detectability across imaging modalities and voxel resolutions and may help explain variability in radiographic detection under controlled conditions.
- 24 March 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (7) , 961
Open AccessComparative Detection and Inter-Modality Agreement of Pulp Stones Using Digital Periapical Radiography and CBCT at Two Voxel Sizes: An Ex Vivo Study
Background/Objectives : Pulp stones are calcified masses within the dental pulp that may complicate endodontic procedures. Although cone beam computed tomography (CBCT) has been reported to detect pulp stones more frequently than two-dimensional radiography, direct comparisons between digital periapical radiography (DPR) and CBCT, particularly at different voxel sizes, remain limited. This study aimed to compare pulp stone detection rates between DPR and CBCT acquired at two voxel sizes and to evaluate inter-modality agreement using a location-based analysis for pulp stone identification in extracted teeth. Methods: Fifty-two extracted human teeth were examined using DPR and CBCT at voxel sizes of 0.2 mm and 0.1 mm under standardized ex vivo conditions. Pulp stones were evaluated in the coronal and radicular regions using a binary scoring system (presence/absence). Detection rates were compared across imaging modalities, and inter-modality agreement was evaluated using McNemar’s test in the analysis stratified by pulp stone location. Associations between pulp stone detection and age, gender, tooth status, and stone location were explored using chi-square tests. Results: CBCT at 0.1 mm demonstrated the highest detection rate for pulp stones (63.5%), followed by CBCT at 0.2 mm (57.7%) and DPR (50%), with no statistically significant differences among modalities (p > 0.05). Agreement analysis showed that CBCT at 0.2 mm had higher agreement with CBCT at 0.1 mm than DPR, particularly in the coronal region, whereas DPR showed lower agreement in the radicular region. No significant associations were observed between pulp stone detection and age, gender, or tooth status. Conclusions: Under standardized ex vivo conditions, CBCT showed numerically higher pulp stone detection rates than DPR. Location-based agreement analysis indicated greater consistency between CBCT voxel sizes than between CBCT and DPR, particularly in the radicular region. These findings highlight differences in pulp stone detectability across imaging modalities and voxel resolutions and may help explain variability in radiographic detection under controlled conditions.
- Open Access
- 15 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 43781
Exploratory insights into salivary E-cadherin as a non-invasive biomarker in a rat model of diabetes
E-cadherin, an adhesion molecule critical for epithelial integrity, may be downregulated by oxidative stress (OS) in diabetes. While serum E-cadherin has been investigated in various conditions, its presence in saliva and potential as a non-invasive biomarker for diabetes remain poorly understood. This study aimed to evaluate salivary E-cadherin levels in streptozotocin (STZ)-induced diabetic rats and examine their relationship with OS markers, assessing the potential of E-cadherin as a non-invasive early diagnostic biomarker for diabetes. Twenty male Wistar rats were randomly assigned to control and diabetic groups. The diabetic model was established by administering a single intraperitoneal injection of 65 mg/kg STZ. Saliva was collected via pilocarpine stimulation, and blood samples were obtained for serum analysis. Salivary and serum E-cadherin levels, alongside serum OS markers including malondialdehyde (MDA), glutathione (GSH), superoxide dismutase (SOD), and catalase (CAT) were measured. Pearson’s correlation assessed relationships between E-cadherin and OS markers. Diabetic rats exhibited significantly lower salivary E-cadherin levels (0.60 ± 0.15 ng/ml) compared to controls (1.21 ± 0.45 ng/ml; p < 0.05). Serum E-cadherin levels were higher than salivary levels in both groups (Control: 18.17 ± 2.23 vs. 1.21 ± 0.45 ng/ml, p < 0.001; Diabetic: 15.64 ± 3.62 vs. 0.60 ± 0.15 ng/ml, p < 0.001), but serum E-cadherin was also reduced in diabetic rats (15.64 ± 3.62 ng/ml) compared to controls (18.17 ± 2.23 ng/ml; p < 0.05). Diabetic rats showed elevated MDA (1.32 ± 0.03 nmol/ml vs. 0.50 ± 0.04 nmol/ml in controls; p < 0.001) and decreased antioxidant markers: GSH (0.76 ± 0.06 vs. 2.55 ± 0.04 µg/ml; p < 0.001), SOD (0.11 ± 0.02 vs. 0.18 ± 0.02 inhibition rate; p < 0.001), and CAT (2.02 ± 0.17 vs. 4.84 ± 0.56 mU/ml; p < 0.001). Furthermore, significant negative correlations were observed between E-cadherin and MDA levels (p < 0.05), while salivary E-cadherin positively correlated with GSH (p < 0.01) and SOD (p < 0.05). This preclinical investigation is the first to show that salivary E-cadherin levels are reduced in diabetic rats and correlate with serum levels, indicating that saliva may reflect systemic changes. Associations with oxidative stress markers suggest that oxidative imbalance contributes to E-cadherin downregulation. These findings provide preliminary evidence for salivary E-cadherin as a promising non-invasive biomarker for early detection and monitoring of diabetes-related epithelial dysfunction. Its translational potential lies in enabling simple, stress-free, and accessible screening approaches that could aid in early diagnosis and disease management in clinical settings.
- 15 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 43781
Open AccessExploratory insights into salivary E-cadherin as a non-invasive biomarker in a rat model of diabetes
E-cadherin, an adhesion molecule critical for epithelial integrity, may be downregulated by oxidative stress (OS) in diabetes. While serum E-cadherin has been investigated in various conditions, its presence in saliva and potential as a non-invasive biomarker for diabetes remain poorly understood. This study aimed to evaluate salivary E-cadherin levels in streptozotocin (STZ)-induced diabetic rats and examine their relationship with OS markers, assessing the potential of E-cadherin as a non-invasive early diagnostic biomarker for diabetes. Twenty male Wistar rats were randomly assigned to control and diabetic groups. The diabetic model was established by administering a single intraperitoneal injection of 65 mg/kg STZ. Saliva was collected via pilocarpine stimulation, and blood samples were obtained for serum analysis. Salivary and serum E-cadherin levels, alongside serum OS markers including malondialdehyde (MDA), glutathione (GSH), superoxide dismutase (SOD), and catalase (CAT) were measured. Pearson’s correlation assessed relationships between E-cadherin and OS markers. Diabetic rats exhibited significantly lower salivary E-cadherin levels (0.60 ± 0.15 ng/ml) compared to controls (1.21 ± 0.45 ng/ml; p < 0.05). Serum E-cadherin levels were higher than salivary levels in both groups (Control: 18.17 ± 2.23 vs. 1.21 ± 0.45 ng/ml, p < 0.001; Diabetic: 15.64 ± 3.62 vs. 0.60 ± 0.15 ng/ml, p < 0.001), but serum E-cadherin was also reduced in diabetic rats (15.64 ± 3.62 ng/ml) compared to controls (18.17 ± 2.23 ng/ml; p < 0.05). Diabetic rats showed elevated MDA (1.32 ± 0.03 nmol/ml vs. 0.50 ± 0.04 nmol/ml in controls; p < 0.001) and decreased antioxidant markers: GSH (0.76 ± 0.06 vs. 2.55 ± 0.04 µg/ml; p < 0.001), SOD (0.11 ± 0.02 vs. 0.18 ± 0.02 inhibition rate; p < 0.001), and CAT (2.02 ± 0.17 vs. 4.84 ± 0.56 mU/ml; p < 0.001). Furthermore, significant negative correlations were observed between E-cadherin and MDA levels (p < 0.05), while salivary E-cadherin positively correlated with GSH (p < 0.01) and SOD (p < 0.05). This preclinical investigation is the first to show that salivary E-cadherin levels are reduced in diabetic rats and correlate with serum levels, indicating that saliva may reflect systemic changes. Associations with oxidative stress markers suggest that oxidative imbalance contributes to E-cadherin downregulation. These findings provide preliminary evidence for salivary E-cadherin as a promising non-invasive biomarker for early detection and monitoring of diabetes-related epithelial dysfunction. Its translational potential lies in enabling simple, stress-free, and accessible screening approaches that could aid in early diagnosis and disease management in clinical settings.
- Open Access
- 8 May 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1556830
Revisiting the molecular landscape of Rosai-Dorfman disease: insights from whole exome sequencing of Saudi patients
Rosai-Dorfman disease (RDD) has traditionally been viewed as a reactive histiocytic disorder, defined by its unique clinical features and immunophenotype. However, recent genetic studies suggest a more complex molecular landscape, challenging the notion of RDD as solely reactive and hinting at a possible neoplastic component. Mutations in MAPK/ERK pathway genes, such as KRAS and MAP2K1, have been observed in up to 33% of cases. Additional genetic alterations in cell cycle regulation, DNA repair, and other processes, along with low-frequency BRAF mutations, further emphasize this complexity. To better understand the molecular basis of RDD and enhance diagnostic precision, we conducted whole exome sequencing (WES) on seven Saudi patients with RDD, comparing their genetic profiles with existing literature. While no kinase driver mutations were detected, our analysis revealed thirteen distinct mutations. Recurrent mutations were observed in CD207 and TDG, each found in six patients. CD207 is linked to antigen processing, while TDG is associated with DNA repair. MUC4 and PDS5A mutations, related to cell cycle regulation, were each identified in three patients. DNMT3A mutation, affecting DNA methylation, was found in two patients. Single mutations were observed in BRCA1, LATS2, ATM, USP35, and CIC, associated with DNA repair, the ubiquitin proteasome pathway, and transcriptional regulation respectively. These findings offer insights into the genetic makeup of RDD, revealing candidate genes and expanding our understanding of the disease’s molecular complexities. By uncovering these genetic markers, this study contributes to the ongoing efforts to develop more accurate diagnostic tools and refine the classification of RDD, paving the way for improved patient care and disease management.
- 8 May 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1556830
Open AccessRevisiting the molecular landscape of Rosai-Dorfman disease: insights from whole exome sequencing of Saudi patients
Rosai-Dorfman disease (RDD) has traditionally been viewed as a reactive histiocytic disorder, defined by its unique clinical features and immunophenotype. However, recent genetic studies suggest a more complex molecular landscape, challenging the notion of RDD as solely reactive and hinting at a possible neoplastic component. Mutations in MAPK/ERK pathway genes, such as KRAS and MAP2K1, have been observed in up to 33% of cases. Additional genetic alterations in cell cycle regulation, DNA repair, and other processes, along with low-frequency BRAF mutations, further emphasize this complexity. To better understand the molecular basis of RDD and enhance diagnostic precision, we conducted whole exome sequencing (WES) on seven Saudi patients with RDD, comparing their genetic profiles with existing literature. While no kinase driver mutations were detected, our analysis revealed thirteen distinct mutations. Recurrent mutations were observed in CD207 and TDG, each found in six patients. CD207 is linked to antigen processing, while TDG is associated with DNA repair. MUC4 and PDS5A mutations, related to cell cycle regulation, were each identified in three patients. DNMT3A mutation, affecting DNA methylation, was found in two patients. Single mutations were observed in BRCA1, LATS2, ATM, USP35, and CIC, associated with DNA repair, the ubiquitin proteasome pathway, and transcriptional regulation respectively. These findings offer insights into the genetic makeup of RDD, revealing candidate genes and expanding our understanding of the disease’s molecular complexities. By uncovering these genetic markers, this study contributes to the ongoing efforts to develop more accurate diagnostic tools and refine the classification of RDD, paving the way for improved patient care and disease management.
- Open Access
- 19 June 2023
- Published by Elsevier in Saudi Journal of Biological Sciences
- Vol. 30 (7) , 103710
Fatal intracranial haemorrhage in acute promyelocytic leukemia patients with short isoform of PML-RARα: Review of molecular and radiological data
- 19 June 2023
- Published by Elsevier in Saudi Journal of Biological Sciences
- Vol. 30 (7) , 103710
Open AccessFatal intracranial haemorrhage in acute promyelocytic leukemia patients with short isoform of PML-RARα: Review of molecular and radiological data
- Open Access
PHF6 Interacts with LMO2 During Normal Haematopoiesis and in Leukaemia and Regulates Gene Expression and Genome Integrity
The transcriptional mediator LIM domain only 2 (LMO2) forms a large multi-protein complex together with TAL1/LYL1, HEB/E2A, LDB1 and GATA. This complex regulates transcription from the onset of haematopoietic development and during differentiation. Chromosomal re-arrangements involving LMO and other members of the complex are causative for T-cell lymphoblastic leukaemia (T-ALL). We have identified Plant Homeodomain (PHD)-like Finger 6 (PHF6) as a new LMO2 interacting factor. Somatic mutations in PHF6 have been found to occur in several types of leukaemia. We show that PHF6 interacts with LMO2 during the initial stages of the haematopoietic development, myeloid differentiation and in T-ALL. The LMO2/PHF6 complex binds the DNA and regulates linage-specific gene expression. Additionally, a loss or reduction of LMO2 and PHF6 leads to chromosomal instability. PHF6 and LMO2 are required for maintaining levels of γH2AX and 53BP1, where PHF6 is important for γH2AX accumulation and LMO2 has a role in recruiting 53BP1 to γH2AX foci.
Open AccessPHF6 Interacts with LMO2 During Normal Haematopoiesis and in Leukaemia and Regulates Gene Expression and Genome Integrity
The transcriptional mediator LIM domain only 2 (LMO2) forms a large multi-protein complex together with TAL1/LYL1, HEB/E2A, LDB1 and GATA. This complex regulates transcription from the onset of haematopoietic development and during differentiation. Chromosomal re-arrangements involving LMO and other members of the complex are causative for T-cell lymphoblastic leukaemia (T-ALL). We have identified Plant Homeodomain (PHD)-like Finger 6 (PHF6) as a new LMO2 interacting factor. Somatic mutations in PHF6 have been found to occur in several types of leukaemia. We show that PHF6 interacts with LMO2 during the initial stages of the haematopoietic development, myeloid differentiation and in T-ALL. The LMO2/PHF6 complex binds the DNA and regulates linage-specific gene expression. Additionally, a loss or reduction of LMO2 and PHF6 leads to chromosomal instability. PHF6 and LMO2 are required for maintaining levels of γH2AX and 53BP1, where PHF6 is important for γH2AX accumulation and LMO2 has a role in recruiting 53BP1 to γH2AX foci.